SHOUTI
ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
SHOUTI
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical Product Research
Founded:
2016-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.shoutipharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
207 M USD
Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail GoDaddy DNS Cloudflare Hosting Microsoft DMARC DKIM
Similar Organizations
ArriVent Biopharma
ArriVent develops pharmaceutical products to cure presently untreatable cancer.
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
Hendrick Resources
Hendrick Resources specializes in the discovery and development of precious and base metals.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Productboard
Productboard is a product management system that helps organizations get the right products to market faster.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Piper Heartland Healthcare Capital
Piper Heartland Healthcare Capital investment in Series B - ShouTi
Deep Track Capital
Deep Track Capital investment in Series B - ShouTi
Surveyor Capital
Surveyor Capital investment in Series B - ShouTi
Woodline Partners
Woodline Partners investment in Series B - ShouTi
TF Capital
TF Capital investment in Series B - ShouTi
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - ShouTi
Casdin Capital
Casdin Capital investment in Series B - ShouTi
Eight Roads Ventures
Eight Roads Ventures investment in Series B - ShouTi
Cormorant Asset Management
Cormorant Asset Management investment in Series B - ShouTi
TCG Crossover
TCG Crossover investment in Series B - ShouTi
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-21 | ShouTi Appoints Ding Ding, Ph.D., as Chief Financial Officer |
Official Site Inspections
http://www.shoutipharma.com Semrush global rank: 1.97 M Semrush visits lastest month: 10.92 K
Unable to get host informations!!!
More informations about "ShouTi"
ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to …
Feb 17, 2022 “With all of these breakthrough technologies under one roof, and access to the …See details»
Structure Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Structure Therapeutics creates life-changing medicines …See details»
ShouTi Secures $100 Million Series B Financing to Accelerate ...
Oct 20, 2021 ShouTi Secures $100M Series B Financing to Accelerate Development of …See details»
ShouTi Strengthens Board with Appointment of Daniel G. Welch as ...
Jan 19, 2022 San Francisco and Shanghai – January 20, 2022 – ShouTi Inc., a clinical-stage …See details»
ShouTi Strengthens Board With Appointment of Daniel G. Welch …
Jan 20, 2022 For more information, visit www.shoutipharma.com and follow the company on …See details»
ShouTi Secures $100 Million Series B Financing to Accelerate ...
Oct 20, 2021 ShouTi Inc., a clinical-stage biopharmaceutical company creating life-changing …See details»
ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to …
Feb 17, 2022 “With all of these breakthrough technologies under one roof, and access to the …See details»
ShouTi Secures $100 Million Series B Financing to Accelerate ...
Oct 20, 2021 San Francisco and Shanghai – Oct. 20, 2021 – ShouTi Inc., a clinical-stage …See details»
Receptos founder returns with ShouTi and $100M for oral drugs to …
Oct 20, 2021 First it was Syrrx. Then, Receptos. Now, Raymond Stevens, Ph.D., has …See details»
ShouTi Strengthens Board With Appointment of Daniel G. Welch …
For more information, visit www.shoutipharma.com and follow the company on Twitter …See details»
ShouTi Appoints Sharon Tetlow to Board of Directors
Mar 29, 2022 For more information, visit www.shoutipharma.com and follow the company on …See details»
ShouTi secures $100M to hit biologic and peptide targets with …
Oct 20, 2021 ShouTi Pharmaceuticals, a startup that brings computational techniques to drug …See details»
ShouTi Appoints Sharon Tetlow to Board of Directors
Mar 29, 2022 San Francisco and Shanghai – March 29, 2022 – ShouTi Inc., a clinical-stage …See details»
ShouTi Appoints Ding Ding, Ph.D., as Chief Financial Officer
Dec 21, 2021 For more information, visit www.shoutipharma.com and follow the company on …See details»
ShouTi Secures $100 Million Series B Financing, Qiming Participated
Oct 29, 2021 SAN FRANCISCO & SHANGHAI--(BUSINESS WIRE)--ShouTi Inc., a clinical …See details»
Structure Therapeutics Extends Financing, Advances Diabetes and …
Aug 1, 2022 San Francisco and Shanghai – August 1, 2022 – Structure Therapeutics Inc. …See details»
Structure Therapeutics, formerly known as ShoutTi, files for $100M …
Jan 13, 2023 Chinese-American drug developer Structure Therapeutics (GPCR), formerly …See details»
Structure Therapeutics | World Class Medicines. By Design.
Designing orally available, superior medicines to transform patients’ lives across the globe. …See details»
ShouTi Strengthens Board With Appointment of Daniel G. Welch …
Jan 20, 2022 SAN FRANCISCO & SHANGHAI--(BUSINESS WIRE)-- ShouTi Inc., a clinical …See details»
Structure Therapeutics Extends Financing, Advances ... - Business …
Aug 1, 2022 SAN FRANCISCO & SHANGHAI--(BUSINESS WIRE)--Structure Therapeutics …See details»